GAT-Sepharose, demonstrating that the serologically detectable GAT fragment(s) is (are) lost during such purification. The GT-TsF prepared from H-2 k mice can be bound by an anti-I-J k Sepharose adsorbent, confirming for the polypeptide-specific TsF the presence of I-J determinants reported by Tada et al. to be on protein-specific T~F. Studies by Waltenbaugh et al. (16) on the mechanism of action of crude T~F preparations demonstrated that in vivo administration of GT-T~F or GAT-T~F to naive animals induces antigen-specific suppressor T cells in such recipients. This finding suggested that an important function of these T cell-derived antigen-specific factors is the stimulation of a second set of specific T cells to become the effector suppressor T cells actually responsible for inhibition of immune responses. In agreement with these findings, Tada (17) reported that the specific TsF studied in his laboratory was produced by Ly 2,3+ cells and stimulated the generation of T~.
The earlier finding that GAT-TsF in the crude extract was complexed to GAT or a GAT fragment raised the possibility that both GAT-TsF and antigen might be required for efficient induction of GAT-Ts in this model. To resolve this issue and better understand the precise nature and interactions of the cells and factors involved in T-cell-mediated antigen-specific suppression, an in vitro system was designed for inducing Ts under defined conditions. The current study focuses on the production of Ts by GAT-T~F. The data demonstrate that GAT-T~F does indeed induce normal spleen cells to develop antigen-specific T~ in vitro, and that both H-2 determinant-bearing TsF and a small amount of the GAT antigen itself are necessary for this Ts induction.
Materials and Methods
Mice. DBA/1 (H-2 q) mice were purchased from The Jackson Laboratory (Bar Harbor, Me.). Mice were maintained on laboratory chow and acidified-chlorinated water ad lib., and used at 10-16 wk of age. Animals were always rested for 7-14 days after receipt before inclusion in experiments, and were sex-and age-matched in any single experiment.
Antigens. GAT, -50,000 tool wt (lot VI), was purchased from Miles Laboratories Inc. (Elkhart, Ind.). Methylated bovine serum albumin (MBSA) was obtained from Worthington Biochemical Corp. (Freehold, N. J.) and GAT-MBSA complexes, sheep erythrocytes (SRBC; GIBCO, Grand Island, N. Y.), and GAT were prepared for use as previously described (18) . Ovalbumin (OVA; Miles Laboratories) was trinitrophenylated by reacting the protein, at 10 mg/ ml in 0.5% sodium carbonate, with picryl chloride (Nutritional Biochemicals Corporation, Cleveland, Ohio) equal to 5% of the total protein weight for 2 h at room temperature, followed by exhaustive dialysis against phosphate-buffered saline. The preparation used in these studies contained approximately 6 trinitrophenyl groups per OVA molecule (TNP~OVA).
Preparation and Immunoabsorbent Purification of Cell-Free Extracts. Cell-free extracts were prepared as previously reported (13) . Briefly, DBA/1 mice were inoculated intraperitoneally (i.p.) with Maalox (William H. Rorer Inc., Fort Washington, Pa.) alone or with 10 jzg GAT in Maalox. 3-7 days later, cell suspensions were prepared from thymus and spleen. The cells were sonicated at 50-60 W for 5 rain at 4°C, and the lysate centrifuged at 40,000 g at 4°C for 1 h. The supernates (Maalox [control] extract or crude GAT-T~F, respectively) were collected and stored at -80°C until use. Purified GAT-TsF was prepared by 2 M KC1 elution of the suppressive material bound to a GAT-Sepharose column followed by gel filtration to remove excess salt, as reported previously (13) .
The presence of H-2 determinants in the active extracts was assessed by passage of the suppressive material over Sepharose immunoabsorbents prepared with the immunoglobulin fraction of heat-inactivated specific alloantisera, as described (13) . The antisera used in these studies were obtained from Dr. Martin E. Dorf (Department of Pathology, Harvard Medical School) and consisted of anti-H-2 b serum: (DBA/1 × DBA/2)Fz anti-D1.LP, and anti-KqIq serum: (DBA/2 x B10.BR)F1 anti-B10.T(6R), raised by repeated inoculation with lymphoid cells, followed by pooling of high-titered individual sera.
In Vitro Assay of GAT-T,F.
The direct suppressive activity of Maalox extract or of the crude and purified GAT-TaF was assayed by a modification of the previously reported Mishell-Dutton culture system (18, 19) . In brief, replicate 1-ml cultures of 7.5 x l0 s viable DBA/1 spleen cells in Mishell-Dutton medium plus 10 mM N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid (Hepes; MDH) were established in the 16-ram wells of a 24-sample multiwell dish (Linbro FB-16-24TC; Linbro Chemical Co., New Haven, Conn.). Cultures contained either no extract or various dilutions (1/400-1/51,200) of Maalox extract or GAT-TsF, and either 1 pg GAT as GAT-MBSA or 2 x 10 e SRBC. The cultures were incubated at 37°C with rocking in 7% 03, 10% CO~, 83% N2, and the GAT or SRBC plaque-forming cell (PFC) responses measured 5 days later, as previously described (18) . Results are expressed as IgG GAT-PFC per culture of 7.5 x 10 e cells.
In Vitro Induction and in Vivo Assay of GAT-T,.
Single cell suspensions of washed DBA/1 spleen cells were prepared in MDH at 20 x 106/ml. 1.5 ml of this cell suspension was mixed in 60-mm tissue culture Petri dishes (Falcon Plastics, Oxnard, Calif.) with 1.5 ml of MDH containing either no additions, various amounts of GAT, or various dilutions of Maalox extract or crude or purified GAT-T~F. These cultures were incubated at 37°C with rocking in 7% O2, 10% CO~, 83% N2 for 2 days, then washed four times by centrifugation and resuspended in serum-free Hanks' balanced salt solution at 6 x 10 e viable cells/ml. DBA/1 mice then received 0.5 ml of the washed cell suspensions containing 3 x 10 e viable cells intravenously (i.v.), followed within 1 h by immunization i.p. with the appropriate antigen. PFC per spleen were determined 7 days later with unmodified SRBC, GAT-SRBC, or TNP-horse erythrocytes (20) .
Treatment with Anti-Thy 1.2. T lymphocytes were removed from cell suspensions after T s induction and before transfer in vivo by treatment with anti-Thy 1.2 plus complement (C) as previously described (21) . Briefly, 50 x 107 cultured cells were mixed with 0.2 ml of anti-Thy 1.2 (AKR anti-C3H) or normal mouse serum diluted 1:5 with Eagle's Minimum Essential Medium containing 10 mM N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid (Hepes) and 10% heatinactivated fetal calf serum, incubated 30 rain at 4°C, washed once and resuspended in selected rabbit serum diluted 1:5 as a complement source. After 45 rain at 37°C, the cells were washed three times with serum-free Hanks' balanced salt solution and resuspended to a volume calculated to give 6 x 106 cells/ml before treatment. 0.5 ml of treated cell suspension was then given i.v. to each mouse, followed by immunization with antigen.
Preparation and Use of Purified T Cells. T cells were partially purified from normal DBA/1 spleen cells by passage over nylon wool, essentially as described by Julius et al. (22) . Such "Tcell" preparations contained less than 5% surface immunoglobulin positive cells, as assessed by fluorescence microscopy. These T cells were then cultured as described above for induction of T8 after addition to culture dishes containing Maalox extract or GAT-T,F and X.irradiated (1,500 R) splenic adherent cells from 30 x 106 spleen cells to replace the macrophages lost by nylon wool passage. 1/800 GAT-TsF was ineffective at the 3 x 106 cell dose transferred in this experiment. The $50 (inverse dilution of TsF needed to give 50% suppression of GAT-MBSA responses in vitro) of the GAT-TsF used for these experiments was found to be 1,000-1,200, and thus, only slightly greater (<twofold) than the suppressor induction activity assayed here under quite different conditions. Control (Maalox) extracts did not induce suppressor cells under similar conditions; in fact, in several experiments mice receiving cells incubated with control extracts gave slightly higher responses than mice receiving no cells (data not shown). In other experiments, the number of cells needed to obtain 50% suppression after induction with 1/200 GAT-TsF ranged from 3 x 10 s to 1 x 106, with 2-3 x 10 s cells always giving >85% suppression. Hence, 3 x 10 s cells and 1/200 GAT-TsF were chosen for all subsequent experiments.
Results

Induction of Suppressive Activity in Spleen Cells
Evidence That the Active Suppressor Cell Induced by GAT-T,F is a T Cell.
To establish that the suppression of the GAT-MBSA response seen after transfer of spleen cells incubated with GAT-T~F was indeed due to T lymphocytes, as predicted by analogy with the in vivo GT-T~F studies, two approaches were used. In the first, spleen cells cultured in 1/200 GAT-TsF for 2 days were treated with anti-Thy 1.2 plus C before transfer, and their residual suppressive activity measured. Fig. 2 presents data from a representative experiment of this type. Spleen cells incubated in control extract were not suppressive, whereas cells incubated in 1/200 GAT-TsF caused complete suppression of the GAT-MBSA response. Transfer of cells after anti-Thy 1.2 plus C treatment did not cause a detectable suppression. In several other similar experiments, the same elimination of suppressor cell activity was seen with a different preparation of anti-Thy 1.2 serum, and no reduction in suppression seen after treatment with C alone or C plus normal mouse serum (data not shown). Table I gives IgG GAT-SPECIFIC PFC/SPLEEN FIo. 2. Sensitivity of in vitro GAT-T,F-induced suppressor cells to treatment with antiThy 1.2 plus C. Same protocol as for Fig. 1 , except that some cells were treated as described in Materials and Methods with anti-Thy 1.2 plus C before transfer. The purified T cells cultured with GAT-TsF gave the same complete suppression of the GAT-MBSA response as seen when 3 × 106 GAT-T~F cultured whole spleen cells were transferred. Taken together, the anti-Thy 1.2 and nylon wool purification experiments are strong evidence that the suppression of the GAT-MBSA response seen after transfer of spleen cells incubated with GAT-T~F is due to T lymphocytes.
TABLE I
Induction of GAT-Specific T, in Vitro using Purified T Cells and Crude GAT-T,F
Antigen Specificity of Suppression Mediated by GAT-T,F-Induced Suppressor T Cells.
Although T s cells and TsF in the GAT-GT systems have always proved to be antigen specific, reports of nonspecific T suppressor cells (2, 23) make necessary documentation of the specificity of the T~ induced by GAT-Ts F. able to selectively suppress the IgG GAT-specific PFC response to GAT-MBSA and not the IgG SRBC or IgM TNP~-OVA response. Some decrease in the IgG TNPvOVA response is observed upon transfer of DBA/1 cells cultured with control extract or GAT-TsF, but no differences in the effects of cells incubated with these two materials were found, in contrast to their quite distinct effects on the GAT-MBSA response. Although the cause of this mild nonspecific suppression is not known at present, the data clearly reveal the GAT-specific activity of the GAT-TsF-induced Ts in this system.
The GAT-T,F Which Stimulates the Development of T, Bears H-2 (K and/or I) Determinants.
Characterization of antigen-specific TsF revealed the presence of H-2, and more specifically, I-J determinants on the active material (13, 15) . To ascertain whether such H-2 determinants were present on the moiety responsible for T s induction by TsF, GAT-TsF from DBA/1 (H-2q) mice was passed over an anti-H-2 b or anti-KqI q Sepharose immunoadsorbent. The material that passed through the column was tested for induction of Ts in vitro. The data from one such experiment are presented in Fig. 4 . As can be seen, 1/200 GAT-TsF induces active T,, as does 1/200 GAT-T~F passed over a control anti-H-2 b immunoadsorbent. However, the ability to induce T~ is removed from GAT-TsF by passage over an anti-KQI q column, indicating that at least one component necessary for stimulation of T~ bears K q and/or Iq determinants, and thus is identical to previously studied TsF in this regard.
Role of Antigen in the Induction of T, in Vitro by GAT-T,F. It was
previously demonstrated (13) that the material in crude GAT-T~F able to suppress GAT-MBSA responses could be removed by a rabbit anti-GAT Sepharose column, implying that GAT was complexed to the suppressive moiety. It was also shown that crude GAT-TsF bound to and could be eluted from a GATSepharose adsorbent. Furthermore, column-purified GAT-T~F retained full suppressive activity upon direct in vitro testing in the presence of GAT-MBSA. Further studies revealed that the purified GAT-T~F recovered from such a GAT-Sepharose column lacked the serologically detectable piece of GAT. These findings raised the issue of whether GAT-T ,F needs to be bound to GAT for the efficient stimulation of GAT-specific suppressor T cells. As a first step in answering this question, free native GAT, known to induce GAT-T, in vivo, was tested for T6 induction in vitro. Fig. 5 reveals that spleen cells incubated with 1-5 ~zg of GAT per culture (0.33-1.67 ~g/ml) developed GAT-T6 that were capable of complete suppression of the GAT-MBSA response when 3 x 106 cells were transferred per recipient. Spleen cells cultured with 50 ng GAT were not significantly suppressive under these conditions. These data are consistent with earlier work on direct suppression of DBA/1 responses in culture by free GAT, in which >0.1 ~g/ml was found necessary for elimination of GAT-MBSA PFC responses (24) . They also indicate that the amount of GAT in the crude extract at the dilution used was insufficient to be responsible by itself for T6 induction in vitro, because 1/200 dilutions of the crude extracts would contain a maximum of 100 ng of GAT if all the antigen injected in the mice from which the GAT-T=F was prepared were recovered in the extract. This is consistent as well with the requirement for an H-2 coded product for the induction of suppressor cells. Fig. 6 shows the results of titrations of the crude GAT-TsF used in these studies and of two different preparations of purified GAT-T=F directly on the in vitro PFC response of DBA/1 spleen cells to GAT-MBSA. None of the extracts suppressed the control SRBC responses at any concentration tested (data not shown). Control (Maalox) extracts had no effect or slightly suppressed GAT-MBSA responses at the highest concentration tested, and had either no effect or enhanced GAT-MBSA responses at greater dilutions. The crude GAT-TsF had an $50 of between 1,000-1,600 on repeated testing, whereas the two purified GAT-T=F had $50 of between 10,000-16,000, 10-fold higher than the crude material from which they were derived. This increase was due in part to concentration of the material during column purification (fivefold) and a repeatedly observed increase in suppressive activity of purified material of about twofold, probably due to the removal of nonspecific culture-enhancing materials which partially mask the suppressive activity of crude extracts (13) .
The two purified GAT-TsF preparations were then tested for induction of 'Is in vitro in the absence of added antigen. Fig. 7A presents data for one preparation of purified GAT-TsF, and 7 B for the second, with the data taken from one of three or four replicate experiments. The crude GAT-TsF at 1/200 final dilution clearly induced 'Is capable of suppressing the GAT-MBSA response in each experiment. The purified materials were used as 1/200 dilution of the concentrated, 10-fold more active material and yet both failed to induce any significant 'Is activity. 10 or 50 ng of GAT alone yielded no significant suppression, as expected. However, cells incubated with both low doses of GAT and purified GAT-TsF demonstrated almost complete suppression of GAT-MBSA responses upon transfer. Thus, these data indicate that for induction of GAT-specific Ts in vitro by GAT-TsF, both an H-2 coded antigen-specific material and a small amount of GAT are required. Discussion The activity of both crude and purified soluble GAT-suppressive extracts was investigated by a combination of in vitro and in vivo techniques. In agreement with earlier in vivo studies on the mechanism of action of GT-TsF and GAT-TsF by Waltenbaugh et al. (16), we have shown that addition of low concentrations of GAT-TsF to cultures of syngeneic spleen cells stimulates the development of GAT-Ts which after transfer are able to suppress the GAT-MBSA response of recipient mice. The cells responsible for this suppression were shown to be T lymphecytes, both by using purified T cells for suppressor-cell induction in vitro and by elimination of suppressive activity of cells cultured with GAT-T~F by treatment with anti-Thy 1.2 plus C before cell transfer. The suppression was demonstrated to be antigen specific with both particulate (SRBC) and soluble (TNP-OVA) control antigens. For the induction of GAT-Ts, a moiety bearing H-2 (K q and/or I q) determinants and also GAT itself, either bound to the crude GAT-TsF or added in nanogram amounts to antigen-free purified T~F, were both required. Purified GAT-T~F, which lacks detectable GAT, was shown to be suppressive when tested directly on spleen cell cultures containing GAT-MBSA (Fig. 6 ), but not to be able to induce T~ in the absence of added GAT (Fig. 7) . This suggests that the GAT-MBSA provides the requisite GAT antigen in the assay cultures for induction by purified GAT-T~F of GATspecific T~ which in turn suppress the GAT-MBSA response.
These results extend earlier observations on the ability of extracts of T-cell preparations containing suppressor T lymphocytes to interfere with immune responses. Several laboratories have reported on such TsF. Tada et al. originally demonstrated that mice receiving two injections of soluble protein antigen, such as keyhole limpet hemocyanin (KLH) had Ts and could yield T~F with properties of antigen specificity, size, and the presence of la determinants similar to those recently described for the GAT-and GT-TsF (9, 10, 25). They did not, however, describe any antigen to be present in their active TsF materials, in contrast with crude GAT-T~F. The KLH TsF described by Tada also appears to induce certain antigen-primed T cells to become mature T s in the presence of added KLH (17) . This resembles the results reported here, and careful analysis of the material necessary for this effect may reveal whether both antigen and/-coded factor are always necessary for the induction of suppressor T cells by TsF. In this regard, it is important to determine the reason for the discrepancy between the strict I-J matching required for KLHTsF activity (4) and the lack of such restrictions reported for GAT-and GT-T~F (12, 14) . The possibility that the presence of antigen in the latter TsF preparations may mask inherent I-J restrictions must be considered. Also, because KLH-T~F is assayed with secondary responses whereas GAT-TsF is assayed on primary responses, it is possible that the l-J restriction is a result of the primed state of the target T cells in the KLH model.
The present experiments do not establish definitively that the active material in the GAT-T~F responsible for T~ induction has both la (more particularly I-J) determinants and antigen-binding activity in the same molecular complex, as was shown for GT-TsF responsible for direct in vitro suppression (15) . Purified GT-Ts F eluted sequentially from GT-Sepharose and anti-l-J Sepharose is now being tested for Ts induction to answer this precise question and also to test for the requirement for additional GT antigen, to confirm the findings for purified GAT-TsF reported here. The ability of GAT-TsF and GT-TsF to act across H-2 barriers in T~ induction is being examined with preliminary data suggesting no absolute requirements for either immune response gene or I-J subregion matching (R. N. Germain, unpublished observations).
Several other soluble T-cell-derived suppressor substances have been described (26) (27) (28) (29) . One of these is a suppressive supernate from T~-containing spleen cells in the allotype suppression model studied by Herzenberg et al. (30) . This factor is not antigen-specific, but seems to directly inactivate allotypespecific helper T cells without the induction of allotype-specific Ts. It is thus clearly distinct in effect from the KLH-or GAT-T~F. Whether a similar material active directly on helper T cells is present in extracts from antigen-, as opposed to allotype-suppressed mice is not yet known, but might be postulated to be the product of the T~ induced by the GAT-TsF studied here.
The ability of GAT-T~F to induce GAT-specific Ts raises several other questions concerning the pathways of cellular and soluble factor activity responsible for T lymphocyte-dependent suppression. The studies of Debr$ et al. (31) have shown that mice which normally produce Ts in response to GT fail to do so after cyclophosphamide pretreatment. However, such mice and A/J mice (which have a genetic inability to be suppressed by GT) can be suppressed by GT-T~F (14, 31) . Taken together with the data in this paper, it would seem that at least two distinct T cells are involved in immune suppression, one of which produces TsF in response to antigen, and the second of which is activated by this TsF plus antigen to become the effector Ts. The experiments of Feldman and co-workers on T1-T2 cell interaction in suppression (32) , and Ly and Ia phenotyping of Ts (33) , support this concept. In addition, this two-cell model of producer and acceptor cells superficially resembles that described by Munro and Taussig (34) for factor production by T helper cells and factor acceptance by B cells. The existence of distinct Ir gene defects at these two sites has been documented in the branched copolymer models and suggests that similar types of defects may exist in mice that fail to produce suppression after GAT or GT immunization. A possible example of a GT factor-deficient mouse able to yield T~ when given active GT-TsF is the A/J mouse, and studies are currently underway to detect the reciprocal defect, in the hope that such mice will help map the cellular loci of action of the complementing Is genes in the I-A or I-B and I-C subregions responsible for GT suppression.
It should be noted, however, that acceptors for the I region portion only of these various factors is not a complete explanation for producer-acceptor cell interactions because the current work reveals a need for antigen as well in Ts induction. The role of this antigen may be to aid in focusing the T~F on the appropriate antigen-specific Ts precursor in high concentrations. The I region acceptor could then recognize the T~F and trigger the cell. This would be analogous to the model for specific B-cell activation by low concentrations of haptenated polyclonal B-cell activators proposed by Coutinho and M611er (35) . Conversely, a two-signal model can be proposed in which both antigen receptor binding and factor acceptor binding of their respective ligands is necessary for Ts triggering. The potential roles of TsF acceptors and antigen receptors in genetic restriction phenomena and Ts triggering can now be explored by sequential pulsing of lymphocytes with antigen and TsF, using the in vitro model detailed here. Summary A combination of in vitro and in vivo techniques were used to explore the mode of action of both crude and purified suppressive extracts specific for the random copolymer L-giutamic acid6°-L-alanine3°-L-tyrosine ~° (GAT-T~F) obtained from nonresponder DBA/1 (H-2q) mice. Normal DBA/1 spleen cells were incubated under modified Mishell-Dutton culture conditions for 2 days together with crude or purified GAT-TsF, and in the presence or absence of free GAT. These cells were then washed extensively and 3 × 106 viable cells transferred to syngeneic recipients, which were challenged at the same time with the immunogenic form of GAT complexed to methylated bovine serum albumin (GAT-MBSA). GAT-specific IgG plaque-forming cells (PFC) in the spleen were assayed 7 days later. In agreement with earlier in vitro studies on the action of GAT-T~F, it was demonstrated that under these conditions, low concentrations of GAT-T~F stimulated the development of cells which, aider transfer, are able to suppress the GAT PFC response to GAT-MBSA. The cells responsible for this suppression were shown to be T lymphocytes by using nylon wool-purified T cells for suppressor cell induction and by eliminating suppressive activity in cells cultured with crude GAT-T~F by treatment with auti-Thy 1.2 plus C before transfer. The suppressor T cells act in a specific manner failing to suppress significantly either anti-sheep erythrocyte or trinitrophenyl-ovalbumin primary PFC responses. For the induction of GAT-specific suppressor T cells in culture, a moiety bearing H-2(Kq or Iq) determinants and also GAT, either bound to the crude GAT-TsF or added in nanogram amounts to antigen (GAT)-free purified GAT-TsF, were both required.
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